Sara E Espinoza1, Inkyung Jung, Helen Hazuda. 1. Department of Medicine, Division of Geriatrics, Gerontology and Palliative Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA. espinozas2@uthscsa.edu
Abstract
OBJECTIVES: To examine frailty transitions in Mexican American (MA) and European American (EA) older adults. DESIGN: Longitudinal, observational cohort study. SETTING: Socioeconomically diverse neighborhoods in San Antonio, Texas. PARTICIPANTS: Three hundred twelve MA and 285 EA community-dwelling older adults (≥ 65) with frailty information at baseline (1992-1996) and transition information at follow-up (2000/01) in the San Antonio Longitudinal Study of Aging. MEASUREMENTS: Five frailty characteristics (weight loss, exhaustion, weakness, slowness, and low physical activity), frailty score (0-5), and overall frailty state (nonfrail = 0 characteristics, prefrail = 1 or 2, frail = ≥ 3) were assessed at baseline. Transitions (progressed, regressed, or no change) were assessed for frailty score and state. Odds ratios (ORs) of progression and regression in individual characteristics were estimated using generalized estimating equations adjusted for age, sex, ethnic group, socioeconomic status, comorbidity, diabetes, and follow-up interval. RESULTS: Diabetes mellitus with macrovascular complications (OR = 1.84, 95% confidence interval (CI) = 1.02-3.33), fewer years of education (OR = 0.96, 95% CI = 0.93-1.0) and follow-up interval (OR = 1.3, 95% CI = 1.17-1.46) were significant predictors of progression in any frailty characteristic. Mortality increased with greater frailty state, and prefrail individuals were more likely than frail individuals to regress. CONCLUSION: Diabetes mellitus with macrovascular complications and fewer years of education are important predictors of progression in any frailty characteristic. Because of greater risk of death than for the nonfrail state and greater likelihood of regression than for the frail state, the prefrail state may be an optimal target for intervention.
OBJECTIVES: To examine frailty transitions in Mexican American (MA) and European American (EA) older adults. DESIGN: Longitudinal, observational cohort study. SETTING: Socioeconomically diverse neighborhoods in San Antonio, Texas. PARTICIPANTS: Three hundred twelve MA and 285 EA community-dwelling older adults (≥ 65) with frailty information at baseline (1992-1996) and transition information at follow-up (2000/01) in the San Antonio Longitudinal Study of Aging. MEASUREMENTS: Five frailty characteristics (weight loss, exhaustion, weakness, slowness, and low physical activity), frailty score (0-5), and overall frailty state (nonfrail = 0 characteristics, prefrail = 1 or 2, frail = ≥ 3) were assessed at baseline. Transitions (progressed, regressed, or no change) were assessed for frailty score and state. Odds ratios (ORs) of progression and regression in individual characteristics were estimated using generalized estimating equations adjusted for age, sex, ethnic group, socioeconomic status, comorbidity, diabetes, and follow-up interval. RESULTS:Diabetes mellitus with macrovascular complications (OR = 1.84, 95% confidence interval (CI) = 1.02-3.33), fewer years of education (OR = 0.96, 95% CI = 0.93-1.0) and follow-up interval (OR = 1.3, 95% CI = 1.17-1.46) were significant predictors of progression in any frailty characteristic. Mortality increased with greater frailty state, and prefrail individuals were more likely than frail individuals to regress. CONCLUSION:Diabetes mellitus with macrovascular complications and fewer years of education are important predictors of progression in any frailty characteristic. Because of greater risk of death than for the nonfrail state and greater likelihood of regression than for the frail state, the prefrail state may be an optimal target for intervention.
Authors: Jeremy Walston; Mary Ann McBurnie; Anne Newman; Russell P Tracy; Willem J Kop; Calvin H Hirsch; John Gottdiener; Linda P Fried Journal: Arch Intern Med Date: 2002-11-11
Authors: Ellen F Binder; Kenneth B Schechtman; Ali A Ehsani; Karen Steger-May; Marybeth Brown; David R Sinacore; Kevin E Yarasheski; John O Holloszy Journal: J Am Geriatr Soc Date: 2002-12 Impact factor: 5.562
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Sara E Espinoza; Nicolas Musi; Chen-Pin Wang; Joel Michalek; Beverly Orsak; Terry Romo; Becky Powers; Alice Conde; Melody Moris; Darcy Bair-Kelps; Yan Li; Vinutha Ganapathy; Tyson E Jergensen; Lauri C Kelly; Rozmin Jiwani Journal: J Gerontol A Biol Sci Med Sci Date: 2020-01-01 Impact factor: 6.053
Authors: Astrid Etman; Carlijn B M Kamphuis; Tischa J M van der Cammen; Alex Burdorf; Frank J van Lenthe Journal: Eur J Public Health Date: 2014-07-23 Impact factor: 3.367
Authors: Mélany Hars; François R Herrmann; Roger A Fielding; Kieran F Reid; René Rizzoli; Andrea Trombetti Journal: Calcif Tissue Int Date: 2014-08-23 Impact factor: 4.333
Authors: A Hajek; C Brettschneider; T Posselt; C Lange; S Mamone; B Wiese; S Weyerer; J Werle; A Fuchs; M Pentzek; J Stein; T Luck; H Bickel; E Mösch; K Heser; F Jessen; W Maier; M Scherer; S G Riedel-Heller; H-H König Journal: J Nutr Health Aging Date: 2016 Impact factor: 4.075